Howard Marks
Oaktree Capital Management
Howard Marks Core Scientific, Inc stake
total: 853
Oaktree Capital Management CORZ trades
- Total transactions:
- 4
- New positions:
- 1
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2025 Q3
- Held for:
- 4 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Howard Marks holds 4,993,708 Core Scientific, Inc (CORZ) shares with a market value of roughly $127.79M accounting for 2.41% of the overall portfolio. To date, the estimated cost basis is nearly $16.92 for "buy" trades and estimated average "sell" price is $25.59. Oaktree Capital Management first purchased CORZ in 2025 Q3, initially acquiring about 6.40M shares. Since the initial investment in Core Scientific, Inc (CORZ), Oaktree Capital Management has made 3 more transactions.
When did Howard Marks buy Core Scientific, Inc (CORZ)?
Howard Marks first invested in Core Scientific, Inc (CORZ) in 2025 Q3 at the reported quarter-end price of $17.94 per share.
What's the cost basis of Oaktree Capital Management's CORZ stake?
The estimated cost basis for Core Scientific, Inc (CORZ) stake is around $16.92 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $16.92
- Weighted AVG sell price:
- $25.59
Howard Marks's historical trades in Core Scientific, Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.41%
|
4,993,708
|
$25.59
|
$127,788,987
|
-46.60% (-4,357,000)
|
-1.89%
|
|
2026 Q1
|
2.37%
|
9,350,708
|
$14.96
|
$139,886,591
|
+11.98% (+1,000,000)
|
+0.25%
|
|
2025 Q4
|
1.97%
|
8,350,708
|
$14.56
|
$121,586,308
|
+30.47% (+1,950,000)
|
+0.46%
|
|
2025 Q3
|
1.91%
|
6,400,708
|
$17.94
|
$114,828,701
|
new
|
+1.91%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.